Edition:
India

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

2,657JPY
6:23am IST
Change (% chg)

¥-44 (-1.63%)
Prev Close
¥2,701
Open
¥2,663
Day's High
¥2,666
Day's Low
¥2,625
Volume
201,100
Avg. Vol
374,815
52-wk High
¥3,262
52-wk Low
¥1,715

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 6.55 March 2 Dec 2020

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-20 2 6,945.50 7,368.00 6,523.00 --
Quarter Ending Mar-21 1 11,287.00 11,287.00 11,287.00 --
Year Ending Mar-20 11 25,836.50 27,000.00 24,496.00 --
Year Ending Mar-21 7 27,826.40 30,200.00 26,500.00 28,796.70
Year Ending Mar-22 7 32,840.60 42,139.00 28,065.00 32,349.30
Earnings (per share)
Quarter Ending Mar-20 1 6.55 6.55 6.55 --
Year Ending Mar-20 12 28.69 37.45 22.69 --
Year Ending Mar-21 8 40.14 43.00 36.30 42.12
Year Ending Mar-22 8 55.20 78.50 32.84 56.92
LT Growth Rate (%) 1 44.08 44.08 44.08 27.50

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-20 8,576.00 5,770.00 2,806.00 32.72
Quarter Ending Mar-20 6,945.50 6,704.00 241.50 3.48
Quarter Ending Dec-19 5,386.00 6,841.00 1,455.00 27.01
Quarter Ending Sep-19 6,734.00 6,081.00 653.00 9.70
Quarter Ending Jun-19 4,466.00 5,155.00 689.00 15.43

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-20 6,945.50 -- -- -- --
Quarter Ending Mar-21 11,287.00 11,287.00 11,287.00 11,287.00 --
Year Ending Mar-20 25,836.50 -- -- -- --
Year Ending Mar-21 27,826.40 27,826.40 28,123.60 28,123.60 28,796.70
Year Ending Mar-22 32,840.60 32,840.60 32,846.30 32,846.30 32,349.30

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-20 -- -- -- --
Quarter Ending Mar-21 0 0 0 0
Year Ending Mar-20 -- -- -- --
Year Ending Mar-21 0 0 0 2
Year Ending Mar-22 0 0 1 1
Earnings